Objective: This study was designed to evaluate the efcacy of two prophylactic infusion dose of phenylephrine (50 and 75 μg) along with oxytocin
to prevent oxytocin induced hypotension in parturients undergoing caesarean section. With institutional Ethical committeeMaterial and Method:
(IEC) clearance and informed written consent, 420 term parturients undergoing elective caesarean section under SAB were randomly allocated to 3
groups of 140 each. Group C (3 IU oxytocin with normal saline) Group PE50 (3 IU oxytocin with phenylephrine 50μg) Group PE75 (3 IU oxytocin
with phenylephrine 75μg) diluted to 10ml with normal saline and infused over 5 min after baby delivery. No of episode, incidence, duration of
hypotension, rescue vasopressors requirement and any adverse effect observed. In present study, total 67(47.85%), 50 (35.71%) and 26Results:
(18.57%) patients developed hypotension (P= 0.000) and total 110, 65 and 31 episodes (1.64±0.79, 1.30±0.54, 1.19±0.40 per patient) (P= 0.000) in
group C, PE50 and PE75 respectively, total duration of hypotensive episode were 349, 217and 107 mins in three groups, and it consumed 131,75,
35 doses (50 μg each) of phenylephrine (1.95±1.13, 1.50±0.81,1.34± 0.48 dose Per patient) (P= 0.005) and total 97.76±56.69μg, 75 ±40.72 μg ,
67.30 ±24.25 μg (p= 0.003) phenylephrine per patient as rescue vasopressors in group C, PE50 and PE75 respectively. TheConclusion:
prophylactic co-administration of 75μg phenylephrine with oxytocin effectively reduced the incidence of oxytocin induced hypotension in term
parturients undergoing caesarean section under subarachnoid block compared to 50μg phenylephrine.